Project Details
Description
Phase I/II/III Pharmacokinetic and Outcome Study of Inspiration's Recombinant Factor IX Product, IB1001, in Subjects with Hemophilia B
| Status | Finished |
|---|---|
| Effective start/end date | 5/14/10 → 12/31/20 |
Funding
- INSPIRATION BIOPHARMACEUTICALS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.